During the past decade, CMCO conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CMCO" #1 sponsor was "University Hospital, Strasbourg, France" with 3 trials, followed by "University Hospital, Toulouse" with 2 trials sponsored, "Assistance Publique - Hôpitaux de Paris" with 1 trials sponsored, "Hopital Antoine Beclere" with 1 trials sponsored and "Laboratoires Genévrier" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CMCO" #1 collaborator was "Institut National de la Santé Et de la Recherche Médicale, France" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "CMCO" are "Infertility" (3 trials), "Brady-Tachy Syndrome" (1 trials), "Hypertension During Pre-Eclampsia" (1 trials), "Hypothermia" (1 trials) and "Laparoscopy" (1 trials). Many other conditions were trialed in "CMCO" in a lesser frequency.

Most popular intervention types in "CMCO" are "Procedure" (3 trials), "Device" (2 trials), "Drug" (2 trials), "Other" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "- Conventional culture medium for IVF" (1 trials), "- Endocell®" (1 trials), "Aeroneb® Pro (Nektar® Company)" (1 trials), "Comprehensive chromosomal Testing of Trophectoderm biopsies of Blastocysts (CTTEB)" (1 trials) and "ICSI" (1 trials). Other intervention names were less common.

The vast majority of trials in "CMCO" are 7 trials for "Female" genders and 3 trials for "All" genders.

Currently, there are NaN active trials in "CMCO". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in CMCO, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CMCO, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 4 trials that are defined as “Not Applicable".